Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Change in Account Payables (2017 - 2025)

Historic Change in Account Payables for Pediatrix Medical (MD) over the last 9 years, with Q3 2025 value amounting to $760000.0.

  • Pediatrix Medical's Change in Account Payables fell 8538.46% to $760000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.3 million, marking a year-over-year decrease of 12524.55%. This contributed to the annual value of $17.3 million for FY2024, which is 196726.4% up from last year.
  • As of Q3 2025, Pediatrix Medical's Change in Account Payables stood at $760000.0, which was down 8538.46% from -$576000.0 recorded in Q2 2025.
  • In the past 5 years, Pediatrix Medical's Change in Account Payables registered a high of $10.1 million during Q3 2022, and its lowest value of -$7.6 million during Q1 2025.
  • Over the past 5 years, Pediatrix Medical's median Change in Account Payables value was $863000.0 (recorded in 2021), while the average stood at $992055.6.
  • Per our database at Business Quant, Pediatrix Medical's Change in Account Payables crashed by 281243.78% in 2022 and then soared by 40650000.0% in 2024.
  • Pediatrix Medical's Change in Account Payables (Quarter) stood at $966000.0 in 2021, then tumbled by 282.19% to -$1.8 million in 2022, then skyrocketed by 99.94% to -$1000.0 in 2023, then skyrocketed by 406500.0% to $4.1 million in 2024, then plummeted by 81.3% to $760000.0 in 2025.
  • Its last three reported values are $760000.0 in Q3 2025, -$576000.0 for Q2 2025, and -$7.6 million during Q1 2025.